STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Volumn 7, Issue , 2017, Pages 11-23

  Sachdev, Perminder S ^a   Lo, Jessica W ^a   Crawford, John D ^a   Mellon, Lisa ^b   Hickey, Anne ^b   Williams, David ^b   Bordet, Régis ^c   Mendyk, Anne Marie ^c   Gelé, Patrick ^c   Deplanque, Dominique ^c   Bae, Hee Joon ^d   Lim, Jae Sung ^e   Brodtmann, Amy ^f   Werden, Emilio ^f   Cumming, Toby ^f   K€ohler, Sebastian ^g   Verhey, Frans R J ^g   Dong, Yan Hong ^a,h,i   Tan, Hui Hui ^h,i   Chen, Christopher ^h   Xin, Xu ^h   Kalaria, Raj N ^j   Allan, Louise M ^j   Akinyemi, Rufus O ^k   Ogunniyi, Adesola ^k   Klimkowicz Mrowiec, Aleksandra ^l   Dichgans, Martin ^m,n,o   Wollenweber, Frank A ^m   Zietemann, Vera ^m   Hoffmann, Michael ^p   Desmond, David W ^q   Linden, Thomas ^f,r,s   Blomstrand, Christian ^r   Fagerberg, Björn ^t   Skoog, Ingmar ^r   Godefroy, Olivier ^u   Barbay, Mélanie ^u   Roussel, Martine ^u   Lee, Byung Chul ^e   Yu, Kyung Ho ^e   Wardlaw, Joanna ^v   Makin, Stephen J ^w   Doubal, Fergus N ^v   Chappell, Francesca M ^v   Srikanth, Velandai K ^x,y   Thrift, Amanda G ^e,x   Donnan, Geoffrey A ^f   Kandiah, Nagaendran ^z   Chander, Russell J ^z   Lin, Xuling ^z   Cordonnier, Charlotte ^c   Moulin, Solene ^c   Rossi, Costanza ^c   Sabayan, Behnam ^aa   Stott, David J ^w   Jukema, J Wouter ^aa   Melkas, Susanna ^ab   Jokinen, Hanna ^ab   Erkinjuntti, Timo ^ab   Mok, Vincent C T ^ac,ad   Wong, Adrian ^ac,ad   Lam, Bonnie Y K ^ac,ad   Leys, Didier ^c   Hénon, Hilde ^c   Bombois, Stéphanie ^c   Lipnicki, Darren M ^a   Kochan, Nicole A ^a   more..

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c UNIV LILLE   (France)

^d Seoul National University Bundang Hospital   (South Korea)

^e Hallym University   (South Korea)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ Dept Medicine Endocrinol Diabet   (Singapore)

^j NEWCASTLE UNIVERSITY   (United Kingdom)

^k UNIVERSITY OF IBADAN   (Nigeria)

^l JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^m LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁿ GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^o Technische Universität München Munich Cluster for Systems Neurology   (Germany)

^p UNIVERSITY OF CENTRAL FLORIDA   (United States)

^q University of Gothenburg ^*

^r UNIVERSITY OF GOTHENBURG   (Sweden)

^s HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^t UNIVERSITY OF GOTHENBURG   (Sweden)

^u AMIENS UNIVERSITY HOSPITAL   (France)

^v UNIVERSITY OF EDINBURGH   (United Kingdom)

^w UNIVERSITY OF GLASGOW   (United Kingdom)

^x MONASH UNIVERSITY   (Australia)

^y UNIVERSITY OF TASMANIA   (Australia)

^z NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^aa LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^ab HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ac CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^ad Therese Pei Fong Chow Research Centre for Prevention of Dementia   (China)

more..

Author keywords

Cohort studies; Data harmonization; International consortium; Post stroke dementia; Small vessel disease; Vascular cognitive disorder; Vascular dementia

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ATTENTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COGNITIVE FUNCTION TEST; DEMENTIA; EXECUTIVE FUNCTION; HUMAN; LANGUAGE; MEMORY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; TRANSIENT ISCHEMIC ATTACK; VASCULAR COGNITIVE DISORDER;

EID: 85009877455     PISSN: None     EISSN: 23528729     Source Type: Journal    
DOI: 10.1016/j.dadm.2016.10.006     Document Type: Article

References (66)

1. [1] Román, G.C., Managing Vascular Dementia. 2003, Science Press, London.
2. [2] Lobo, A., Launer, L.J., Fratiglioni, L., Andersen, K., Di Carlo, A., Breteler, M.M., et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54 (2000), S4–S9.
3. [3] Rockwood, K., Wentzel, C., Hachinski, V., Hogan, D.B., MacKnight, C., McDowell, I., Prevalence and outcomes of vascular cognitive impairment. Neurology 54 (2000), 447–451.
4. [4] Pohjasvaara, T., Erkinjuntti, T., Ylikoski, R., Hietanen, M., Vataja, R., Kaste, M., Clinical determinants of poststroke dementia. Stroke 29 (1998), 75–81.
5. [5] Sachdev, P.S., Brodaty, H., Valenzuela, M.J., Lorentz, L., Looi, J.C.L., Berman, K., et al. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord 21 (2006), 275–283.
6. [6] Makin, S., Turpin, S., Dennis, M., Wardlaw, J., Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke sub-types. J Neurol Neurosurg Psychiatry 84 (2013), 893–900.
7. [7] Desmond, D.W., Moroney, J.T., Paik, M.C., Sano, M., Mohr, J.P., Aboumatar, S., et al. Frequency and clinical determinants of dementia after ischemic stroke. Neurology 54 (2000), 1124–1131.
8. [8] Pendlebury, S.T., Rothwell, P.M., Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 8 (2009), 1006–1018.
9. [9] Savva, G.M., Stephan, B.C., the Alzheimer's Society Vascular Dementia Systematic Review Group. Epidemiological studies of the effect of stroke on incident dementia: A systematic review. Stroke 41 (2010), e41–e46.
10. [10] Sposato, L.A., Kapral, M.K., Fang, J., Gill, S.S., Hackam, D.G., Cipriano, L.E., et al. Declining incidence of stroke and dementia: coincidence or prevention opportunity?. JAMA Neurol 72 (2015), 1529–1531.
11. [11] Pendlebury, S.T., Stroke-related dementia: rates, risk factors and implications for future research. Maturitas 64 (2009), 165–171.
12. [12] Allan, L., Rowan, E.N., Firbank, M.J., Thomas, A.J., Parry, S.W., Polvikoski, T.M., et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain 134 (2011), 3713–3724.
13. [13] Ivan, C.S., Seshadri, S., Beiser, A., Au, R., Kase, C.S., Kelly-Hayes, M., et al. Dementia after stroke: the Framingham Study. Stroke 35 (2004), 1264–1268.
14. [14] Gottesman, R.F., Hills, A.E., Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol 9 (2010), 895–905.
15. [15] Gorelick, P.B., Scuteri, A., Black, S.E., Decarli, C., Greenberg, S.M., Iadecola, C., et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42 (2011), 2672–2713.
16. [16] METACOHORTS Consortium. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research. Alzheimers Dement, 2016, 10.1016/j.jalz.2016.06.004 [Epub ahead of print].
17. [17] Riley, R.D., Lambert, P.C., Abo-Zaid, G., Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 340 (2010), 521–525.
18. [18] Lyman, G.H., Kuderer, N.M., The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol, 5, 2005, 14.
19. [19] Mellon, L., Brewer, L., Hall, P., Horgan, F., Williams, D., Hickey, A., et al. Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study. BMC Neurol, 15, 2015.
20. [20] Lim, J.S., Kim, N., Jang, M.U., Han, M.K., Kim, S., Baek, M.J., et al. Cortical hubs and subcortical cholinergic pathways as neural substrates of poststroke dementia. Stroke 45 (2014), 1069–1076.
21. [21] Ducroquet, A., Leys, D., Saabi, A.A., Richard, F., Cordonnier, C., Girot, M., et al. Influence of chronic ethanol consumption on the neurological severity in patients with acute cerebral ischemia. Stroke 44 (2013), 2324–2326.
22. [22] Douven, E., Schievink, S.H., Verhey, F.R., van Oostenbrugge, J.R., Aalten, P., Staals, J., et al. The Cognition and Affect after Stroke – a Prospective Evaluation of Risks (CASPER) study: rationale and design. BMC Neurol, 16, 2016, 65.
23. [23] Brodtmann, A., Werden, E., Pardoe, H., Li, Q., Jackson, G., Cowie, T., et al. Charting cognitive and volumetric trajectories after stroke: protocol for the Cognition And Neocortical Volume After Stroke (CANVAS) study. Int J Stroke 9 (2014), 824–828.
24. [24] Akinyemi, R.O., Allan, L., Owolabi, M.O., Akinyemi, J.O., Ogbole, G., Ajani, A., et al. Profile and determinants of vascular cognitive impairment in African stroke survivors: The CogFAST – Nigeria Study. J Neurol Sci 346 (2014), 241–249.
25. [25] Dong, Y., Venketasubramanian, N., Poon-Lap Chan, B.P., Sharma, V.K., Slavin, M.J., Collinson, S.L., et al. Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke. J Neurol Neurosurg Psychiatry 83 (2012), 580–585.
26. [26] Klimkowicz, A., Dziedzic, T., Polczyk, R., Pera, J., Słowik, A., Szczudlik, A., Factors associated with pre-stroke dementia: the cracow stroke database. J Neurol 251 (2004), 599–603.
27. [27] Klimkowicz-Mrowiec, A., Dziedzic, T., Słowik, A., Szczudlik, A., Predictors of poststroke dementia: results of a hospital-based study in Poland. Dement Geriatr Cogn Disord 21 (2006), 328–334.
28. [28] Wollenweber, F.A., Zietemann, V., Rominger, A., Opherk, C., Bayer-Karpinska, A., Gschwendtner, A., The Determinants of Dementia After Stroke (DEDEMAS) Study: protocol and pilot data. Int J Stroke 9 (2014), 387–392.
29. [29] Hoffmann, M., Stroke in the young: The multiethnic prospective durban stroke data bank results. J Stroke Cerebrovasc Dis 7 (1998), 404–413.
30. [30] Hoffmann, M., Higher cortical function deficits after stroke: an analysis of 1,000 patients from a dedicated cognitive stroke registry. Neurorehabil Neural Repair 15 (2001), 113–127.
31. [31] Desmond, D.W., Moroney, J.T., Sano, M., Stern, Y., Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33 (2002), 2254–2260.
32. [32] Lindén, T., Skoog, I., Fagerberg, B., Steen, B., Blomstrand, C., Cognitive impairment and dementia 20 months after stroke. Neuroepidemiology 23 (2004), 45–52.
33. [33] Lindén, T., Blomstrand, C., Skoog, I., Depressive disorders after 20 months in elderly stroke patients: a case-control study. Stroke 38 (2007), 1860–1863.
34. [34] Godefroy, O., Leclercq, C., Roussel, M., Moroni, C., Quaglino, V., Beaunieux, H., French adaptation of the vascular cognitive impairment harmonization standards: the GRECOG-VASC study. Int J Stroke 7 (2012), 362–363.
35. [35] Jokinen, H., Melkas, S., Ylikoski, R., Pohjasvaara, T., Kaste, M., Erkinjuntti, T., et al. Post-stroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol 22 (2015), 1288–1294.
36. [36] Oksala, N., Jokinen, H., Melkas, S., Oksala, A., Pohjasvaara, T., Hietanen, M., et al. Cognitive impairment predicts poststroke death in long-term follow up. J Neurol Neurosurg Psychiatry 80 (2009), 1230–1235.
37. [37] Rasquin, S.M., Lodder, J., Verhey, F.R., The effect of different diagnostic criteria on the prevalence and incidence of post-stroke dementia. Neuroepidemiology 24 (2005), 189–195.
38. [38] Heye, A.K., Thrippleton, M.J., Armitage, P.A., Valdés Hernández Mdel, C., Makin, S.D., Glatz, A., et al. Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability. Neuroimage 125 (2016), 446–455.
39. [39] Heye, A.K., Thrippleton, M.J., Chappell, F.M., Valdés Hernández, M.D., Armitage, P.A., Makin, S.D., et al. Blood pressure and sodium: association with MRI markers in cerebral small vessel disease. J Cereb Blood Flow Metab 36 (2016), 264–274.
40. [40] Valdés Hernández Mdel, C., Armitage, P.A., Thrippleton, M.J., Chappell, F., Sandeman, E., Muñoz Maniega, S., et al. Rationale, design and methodology of the image analysis protocol for studies of patients with cerebral small vessel disease and mild stroke. Brain Behav, 5, 2015, e00415.
41. [41] Yu, K.H., Cho, S.J., Oh, M.S., Jung, S., Lee, J.H., Shin, J.H., et al. Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea. Stroke 44 (2013), 786–788.
42. [42] Srikanth, V.K., Quinn, S.J., Donnan, G.A., Saling, M.M., Thrift, A.G., Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort. Stroke 37 (2006), 2479–2483.
43. [43] Srikanth, V., Anderson, J.F., Donnan, G.A., Saling, M.M., Didus, E., Alpitsis, R., et al. Progressive dementia after first-ever stroke: a community-based follow-up study. Neurology 63 (2004), 785–792.
44. [44] Srikanth, V.K., Thrift, A.G., Saling, M.M., Anderson, J.F., Dewey, H.M., Macdonell, R.A., Increased risk of cognitive impairment 3 months after mild to moderate first-ever stroke: a Community-Based Prospective Study of Nonaphasic English-Speaking Survivors. Stroke 34 (2003), 1136–1143.
45. [45] Kandiah, N., Wiryasaputra, L., Narasimhalu, K., Karandikar, A., Marmin, M., Chua, E.V., et al. Frontal subcortical ischemia is crucial for post stroke cognitive impairment. J Neurol Sci 309 (2011), 92–95.
46. [46] Kandiah, N., Goh, O., Mak, E., Marmin, M., Ng, A., Carotid stenosis: A risk factor for white-matter disease. J Stroke Cerebrovasc Dis 23 (2014), 136–139.
47. [47] Kandiah, N., Chander, R.J., Lin, X.L., Ng, A., Poh, Y.Y., Cheong, C.Y., et al. Cognitive impairment after mild stroke: Development and validation of the SIGNAL2 Risk Score. J Alzheimers Dis 49 (2016), 1169–1177.
48. [48] Cordonnier, C., Leys, D., Dumont, F., Deramecourt, V., Bordet, R., Pasquier, F., et al. What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?. Brain 133 (2010), 3281–3289.
49. [49] Moulin, S., Labreuche, J., Bombois, S., Rossi, C., Boulouis, G., Hénon, H., et al. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol 15 (2016), 820–829.
50. [50] Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L., Buckley, B.M., Cobbe, S.M., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002), 1623–1630.
51. [51] Yang, J., Wong, A., Wang, Z., Liu, W., Au, L., Xiong, Y., et al. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement 11 (2015), 16–23.
52. [52] Liu, W., Wong, A., Au, L., Yang, J., Wang, Z., Leung, E.Y., et al. Influence of amyloid-β on cognitive decline after stroke/transient ischemic attack: three-year longitudinal study. Stroke 46 (2015), 3074–3080.
53. [53] Wang, Z., Wong, A., Liu, W., Yang, J., Chu, W.C., Au, L., et al. Cerebral microbleeds and cognitive function in ischemic stroke or transient ischemic attack patients. Dement Geriatr Cogn Disord 40 (2015), 130–136.
54. [54] Wang, Z., Wong, A., Liu, W., Yang, J., Chu, W.C., Au, L., et al. Pulse pressure and cognitive decline in stroke patients with white matter changes. J Clin Hypertens (Greenwich) 17 (2015), 694–698.
55. [55] Mok, V.C., Lam, B.Y., Wang, Z., Liu, W., Au, L., Leung, E.Y., et al. Delayed-onset dementia after stroke or transient ischemic attack. Alzheimers Dement 12 (2016), 1167–1176.
56. [56] Sachdev, P.S., Brodaty, H., Valenzuela, M.J., Lorentz, L., Looi, J.C., Wen, W., et al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 62 (2004), 912–919.
57. [57] Sachdev, P.S., Lipnicki, D.M., Crawford, J.D., Wen, W., Brodaty, H., Progression of cognitive impairment in stroke/TIA patients over 3 years. J Neurol Neurosurg Psychiatry 85 (2014), 1324–1330.
58. [58] Fortier, I., Raina, P., Van den Heuvel, E.R., Griffith, L.E., Craig, C., Saliba, M., et al. Maelstrom Research guidelines for rigorous retrospective data harmonization. Int J Epidemiol, 2016 pii: dyw075. [Epub ahead of print].
59. [59] Stewart, G.B., Altman, D.G., Askie, L.M., Duley, L., Simmonds, M.C., Stewart, L.A., Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice. PLoS One, 7, 2012, e46042.
60. [60] Psaty, B.M., O'Donnell, C.J., Gudnason, V., Lunetta, K.L., Folsom, A.R., Rotter, J.I., et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from five cohorts. Circ Cardiovasc Genet 2 (2009), 73–80.
61. [61] Schaap, L.A., Peeters, G.M., Dennison, E.M., Zambon, S., Nikolaus, T., Sanchez-Martinez, M., et al. European Project on OSteoArthritis (EPOSA): methodological challenges in harmonization of existing data from five European population-based cohorts on aging. BMC Musculoskelet Disord, 12, 2011, 272.
62. [62] Pluijm, S.M., Bardage, C., Nikula, S., Blumstein, T., Jylha, M., Minicuci, N., et al. A harmonized measure of activities of daily living was a reliable and valid instrument for comparing disability in older people across countries. J Clin Epidemiol 58 (2005), 1015–1023.
63. [63] Sachdev, P.S., Lipnicki, D.M., Kochan, N.A., Crawford, J.D., Thalamuthu, A., Andrews, G., et al. The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: The COSMIC Collaboration. PLoS One, 10, 2015, e0142388.
64. [64] REWARD. The Lancet. Available at: http://www.thelancet.com/campaigns/efficiency/statement. Accessed June 01, 2016.
65. [65] Cochrane Methods: IPD Meta-analysis. The Cochrane collaboration. Available at: http://methods.cochrane.org/ipdma/. Accessed August 22, 2016.
66. [66] Carrillo, M.C., Bain, L.J., Frisoni, G.B., Weiner, M.W., Worldwide Alzheimer's disease neuroimaging initiative. Alzheimers Dement 8 (2012), 337–342.